PRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia (PROPER study).

PRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29046

Enrollment

360

Registered

2012-08-02

Start date

2012-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Use of psychotropic medication by nursing home patients with dementia (Gebruik van psychofarmaca door verpleeghuispatiënten met dementie)

Interventions

Structured, 6-monthly medication review including training/education, control is usual care. Nursing homes randomized to the intervention group, will implement a structured and repeated medication re

Eligibility

Inclusion criteria

Inclusion criteria: All or a random selection of at least 15 nursing home patients of dementia special care units participating in the study.

Exclusion criteria

Exclusion criteria: Objection to participation in this study.

Design outcomes

Primary

Measure	Time frame
Prevalence of patients with appropriate psychotropic medication use.	—

Secondary

Measure	Time frame
Neuropsychiatric symptoms: Neuropsychiatric Inventory-Questionaire (NPI-Q), Cohen-Mansfield Agitation Inventory (CMAI), Nijmegen Observer-Rated Depression scale (NORD), Depression Rating Scale (DRS). Quality of life: Qualidem, Revised Index Social Engagement (RISE). Activities of daily living: Minimum Data Set-Activities of Daily Living-Self-Performance Hierarchy (MDS-ADL-SPH). Side effects: Short Side effect Scale for Psychotropic Drugs (3SPD). Cognition: Severe Impairment Battery-8 (SIB-8).	—

Measure

Time frame

Neuropsychiatric symptoms: Neuropsychiatric Inventory-Questionaire (NPI-Q), Cohen-Mansfield Agitation Inventory (CMAI), Nijmegen Observer-Rated Depression scale (NORD), Depression Rating Scale (DRS). Quality of life: Qualidem, Revised Index Social Engagement (RISE). Activities of daily living: Minimum Data Set-Activities of Daily Living-Self-Performance Hierarchy (MDS-ADL-SPH). Side effects: Short Side effect Scale for Psychotropic Drugs (3SPD). Cognition: Severe Impairment Battery-8 (SIB-8).

—

Contacts

Public ContactD.L. Gerritsen

UMC St. Radboud Afdeling verpleeghuisgeneeskunde Postbus 9101

d.gerritsen@vphg.umcn.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)